I smile mostly because those miners didn't have to walk four hours, in the heat, humidity and sharp edged darkness (without benefit of cap-lamps -- as the batteries were certainly dead) -- to reach a third shaft, to be extracted. The power is back on at Beatrix, and they are all safely topside -- reunited with their families. And Merck did well -- so it is a bonnie Friday morning, indeed here.
. . . .Merck shares rose 0.7% in premarket trade Friday after the company reported a fourth-quarter profit beat and revenue miss. The company reported a loss of $872 million, or a loss of 32 cents per share, after a loss of $594 million, or a loss of 22 cents per share in the year-earlier period. Adjusted earnings-per-share were 98 cents, compared with the FactSet consensus of 94 cents. Revenue rose to $10.43 billion from $10.12 billion, compared with the FactSet consensus of $10.49 billion. The latest results include about $125 million in lost sales relates to the company's June cyber-attack. The company also noted that it took a $2.6 billion charge related to the U.S. corporate tax overhaul. Sales of the company's Januvia, Keytruda and Gardasil beat FactSet expectations. Merck expects 2018 revenue of $41.2 billion to $42.7 billion, compared with the FactSet consensus of $41 billion, and 2018 adjusted EPS of $4.08 to $4.23, compared with the FactSet consensus of $4.10.
Merck also touted its plans to invest $8 billion in U.S. capital projects over the next five years, of a planned $12 billion total, and an intended "one-time, long-term incentive award" for employees in the second quarter. . . .
Onward, with pro bono federal immigration law (DACA Dreamer matters) swirling in my coffee, now. But a great day ahead, and a warm week-long stint in the desert southwest arriving -- in two days' time. Yes.
नमस्ते
No comments:
Post a Comment